Week 6 Antiemetics/Prokinetics/Antihistamines/serotonins Flashcards
(66 cards)
Without prophylaxis, nausea occurs in up to ________ of patients who undergo general anesthesia, but can be as high as ________ in high risk patients
- 40%
- 80%
Stoelting’s, pg. 692
PONV can be further classified as early or late - what time frames align with each classification?
- Early: within 6 hours of emergence
- Late: 6-24 hours after
Stoelting’s, pg. 692
PONV can be associated with increased morbidity due to:
- dehydration
- electrolyte abnormalities
- wound dehiscence
- bleeding
- esophageal rupture
- airway compromise
Stoelting’s, pg. 692
__________ is the muscular contractions within the ileum and jejunum that moves luminal contents back towards the stomach
- antiperistalsis
Stoelting’s, pg. 692
The sequence of events that occur during emesis are controlled by the so-called vomiting “center”, which lies in the ______________
- medulla oblongata
Stoelting’s, pg. 692
Name several of the neurotransmitters that modulate the activity of the vomiting center
Dopamine
Serotonin
Substance P
Ach
y-aminobutyric acid
cannabinoids
Stoelting’s, pg. 692 - Fig 34-1
Slightly cephalad to the vomiting center is the _____________, which detects noxious stimuli in the bloodstream
- Chemoreceptor trigger zone
Stoelting’s, pg. 693
What other anatomic sites (besides the CTZ) can activate the vomiting center?
- vestibular apparatus
- thalamus
- cerebral cortex
- neurons within the GI tract itself
Stoelting’s, pg. 693
Upon activation, the vomiting center sends efferent signals via which cranial nerve(s)?
- 5 - trigeminal
- 7 - facial
- 9 - glossopharyngeal
- 10 - vagus
- 12 - hypoglossal
Stoelting’s, pg. 693
What patient factors are associated with an increased risk of PONV?
- female gender (effects of progesterone/estrogen on CTZ/vomiting center)
- nonsmoker
- history of motion sickness or PONV
Stoelting’s, pg. 693
Among adults, the risk for PONV is ___________ with aging
- reduced
Stoelting’s, pg. 693
What surgical factors are associated with increased risk for PONV?
Longer procedures
Type of procedure
- laparotomy & laparoscopic
- gynecologic
- ENT
- breast
- ortho
Stoelting’s, pg. 693
What anesthetic factors are associated with an increased risk for PONV?
The use of:
Inhaled anesthetics
* nitrous oxide
* neostigmine
* opioids
Stoelting’s, pg. 693
_____________ is a transdermal anticholinergic that can be used for the prevention of PONV
- scopolamine
Stoelting’s, pg. 693
Due to it’s onset of action, scopolamine is most effective when administered _________ before noxious stimuli
- 4 hours
Stoelting’s, pg. 694
Nagelhout, pg. 211
How long can a scopolamine patch remain in place?
- 24-72 hours
Stoelting’s, pg. 694
True or false:
Transdermal scopolamine provides sustained therapeutic plasma concentrations, usually WITHOUT producing the prohibitive side effects such as sedation, cycloplegia (mydriasis/visual disturbances), or drying of secretions
- True
Stoelting’s, pg. 694
Transdermal scopolamine exerts significant antiemetic effects in patients being treated with ____________ or ____________ for postoperative pain
- PCA
- epidural morphine
appears most effective for these indications
Stoelting’s, pg. 694
Nagelhout, pg. 211
Which two anticholinergics may decrease barrier pressure and increases the reflux of acidic fluid into the esophagus?
- atropine (0.6 mg IV)
- glycopyrrolate (0.2-0.3 mg IV)
Stoelting’s, pg. 695
__________ and __________ may enter the CNS and can produce symptoms of central anticholinergic syndrome
- scopolamine
- atropine
Stoelting’s, pg. 694
What are the symptoms of central anticholinergic syndrome?
Symptoms may range from:
- restlessness & hallucinations
to - somnolence & unconsciousness
Stoelting’s, pg. 694
Central anticholinergic syndrome is often mistaken for _____________ as ventilation may be depressed
- delayed recovery from anesthesia
Stoelting’s, pg. 694
______________ is a lipid-soluble anticholinesterase that can be administered as a treatment for central anticholergic syndrome or anticholinergic overdose
- Physostigmine (15-60 mcg/kg)
Stoelting’s, pg. 694-695
Symptoms of anticholinergic overdose may include:
- dry mouth
- difficulty swallowing or talking
- blurred vision/photophobia
- tachycardia
- dry/flushed skin
- increased body temperature (inhibition of sweating)
Stoelting’s, pg. 694-695